These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 11820908

  • 1. Unlicensed and off-label drug use in children: implications for safety.
    Choonara I, Conroy S.
    Drug Saf; 2002; 25(1):1-5. PubMed ID: 11820908
    [Abstract] [Full Text] [Related]

  • 2. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature.
    Lindell-Osuagwu L, Korhonen MJ, Saano S, Helin-Tanninen M, Naaranlahti T, Kokki H.
    J Clin Pharm Ther; 2009 Jun; 34(3):277-87. PubMed ID: 19650250
    [Abstract] [Full Text] [Related]

  • 3. Off-label and unlicensed drug use among neonatal intensive care units in Southern Italy.
    Laforgia N, Nuccio MM, Schettini F, Dell'Aera M, Gasbarro AR, Dell'Erba A, Solarino B.
    Pediatr Int; 2014 Feb; 56(1):57-9. PubMed ID: 23937449
    [Abstract] [Full Text] [Related]

  • 4. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R, Chugh PK, Tripathi CD, Lhamo Y, Gautam S.
    Curr Clin Pharmacol; 2017 Feb; 12(1):18-25. PubMed ID: 28322168
    [Abstract] [Full Text] [Related]

  • 5. Unlicensed and off-label drug use in children: implications for safety.
    Choonara I.
    Expert Opin Drug Saf; 2004 Mar; 3(2):81-3. PubMed ID: 15006712
    [Abstract] [Full Text] [Related]

  • 6. Unlicensed and off-label use of medicines at a neonatology clinic in Italy.
    Dell'Aera M, Gasbarro AR, Padovano M, Laforgia N, Capodiferro D, Solarino B, Quaranta R, Dell'Erba AS.
    Pharm World Sci; 2007 Aug; 29(4):361-7. PubMed ID: 17351821
    [Abstract] [Full Text] [Related]

  • 7. Off-label and unlicensed prescribing for children: have we made any progress?
    Waller DG.
    Br J Clin Pharmacol; 2007 Jul; 64(1):1-2. PubMed ID: 17577389
    [No Abstract] [Full Text] [Related]

  • 8. Risk factors for unlicensed and off-label drug use in children outside the hospital.
    Schirm E, Tobi H, de Jong-van den Berg LT.
    Pediatrics; 2003 Feb; 111(2):291-5. PubMed ID: 12563053
    [Abstract] [Full Text] [Related]

  • 9. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
    Joret-Descout P, Prot-Labarthe S, Brion F, Bataille J, Hartmann JF, Bourdon O.
    Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
    [Abstract] [Full Text] [Related]

  • 10. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
    Neubert A, Dormann H, Weiss J, Egger T, Criegee-Rieck M, Rascher W, Brune K, Hinz B.
    Drug Saf; 2004 Dec; 27(13):1059-67. PubMed ID: 15471510
    [Abstract] [Full Text] [Related]

  • 11. Unlicensed and off-label drug use in hospitalized children in Croatia: a cross-sectional survey.
    Palčevski G, Skočibušić N, Vlahović-Palčevski V.
    Eur J Clin Pharmacol; 2012 Jul; 68(7):1073-7. PubMed ID: 22307225
    [Abstract] [Full Text] [Related]

  • 12. Comparative Assessment of Off-label and Unlicensed Drug Prescriptions in Children: FDA Versus ANSM Guidelines.
    Berdkan S, Rabbaa L, Hajj A, Eid B, Jabbour H, Osta NE, Karam L, Khabbaz LR.
    Clin Ther; 2016 Aug; 38(8):1833-44. PubMed ID: 27392716
    [Abstract] [Full Text] [Related]

  • 13. Off-label and unlicensed drug use in Ayder comprehensive specialized hospital neonatal intensive care unit.
    Gidey MT, Gebretsadkan YG, Tsadik AG, Welie AG, Assefa BT.
    Ital J Pediatr; 2020 Apr 03; 46(1):41. PubMed ID: 32245504
    [Abstract] [Full Text] [Related]

  • 14. Unlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel.
    Gavrilov V, Lifshitz M, Levy J, Gorodischer R.
    Isr Med Assoc J; 2000 Aug 03; 2(8):595-7. PubMed ID: 10979352
    [Abstract] [Full Text] [Related]

  • 15. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study.
    Turner S, Nunn AJ, Fielding K, Choonara I.
    Acta Paediatr; 1999 Sep 03; 88(9):965-8. PubMed ID: 10519338
    [Abstract] [Full Text] [Related]

  • 16. Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.
    Pratico AD, Longo L, Mansueto S, Gozzo L, Barberi I, Tiralongo V, Salvo V, Falsaperla R, Vitaliti G, La Rosa M, Leonardi S, Rotondo A, Avola N, Sgarlata D, Damiano A, Tirantello M, Anzelmo G, Cipolla D, Rizzo A, Russo A, Ruggieri M, Salomone S, Drago F.
    Curr Drug Saf; 2018 Sep 03; 13(3):200-207. PubMed ID: 29921210
    [Abstract] [Full Text] [Related]

  • 17. Off-label and unlicensed use of medicinal products in the neonatal setting in the Slovak Republic.
    Schweigertova J, Durisova A, Dolnikova D, Ondriasova E, Balazova M, Slezakova V, Kuzelova M.
    Pediatr Int; 2016 Feb 03; 58(2):126-31. PubMed ID: 26256925
    [Abstract] [Full Text] [Related]

  • 18. Incidence of unlicensed and off-label prescription in children.
    Langerová P, Vrtal J, Urbánek K.
    Ital J Pediatr; 2014 Feb 04; 40():12. PubMed ID: 24495454
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of unlicensed and off-label antiepileptic drugs prescribed to children: Brazilian Regulatory Agency versus FDA.
    Borges AP, Campos MS, Pereira LR.
    Int J Clin Pharm; 2013 Jun 04; 35(3):425-31. PubMed ID: 23430533
    [Abstract] [Full Text] [Related]

  • 20. Unlicensed and off-label prescription of respiratory drugs to children.
    't Jong GW, Eland IA, Sturkenboom MC, van den Anker JN, Strickerf BH.
    Eur Respir J; 2004 Feb 04; 23(2):310-3. PubMed ID: 14979509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.